Official Title
Feasibility, Usefulness and Evaluation of a Concentrated Rehabilitation for Patients With Persistent Symptoms Post COVID-19
Brief Summary

A large proportion of persons who have had COVID-19 have reported persisted symptoms asfatigue and dyspnea months post infection which affect activities of daily living.The aim of the study is to examine the feasibility and safety of a concentratedrehabilitation program with a mobile application follow-up for persons with persistentsymptoms post COVID-19 infection. We will examine recruitment availability, adherence tothe program, goal achievement, and resources requirements.Methods: A feasibility study with one group pre-post test design with 10-20 personsbetween 18-67 years, with persistent symptoms post COVID-19 will be included. Theintervention is 3+ 1-2 days concentrated rehabilitation with a mobile applicationfollow-up for 3 months.Following assessments wil be used: Cardiopulmonary exercise testing, lung function,functional performance tests, questionnaires regarding dyspnea, fatigue, anxiety,depression, work-status, health status, sleep behavior, physical activity level.Demographic data before and after the intervention will be presented. Focus groupinterview will be done with the participants. The interview will be analysed usingsystematic text condensation.

Detailed Description

In March 2020, the World Health Organization (WHO) declared the COVID-19 outbreak to be a
pandemic, and a year later more than 120 000 000 people are confirmed with the disease.
The disease has caused more than 2 700 000 deaths globally. Norway has a low mortality
rate compared to rest of the world. However, a large proportion (10-33%) of the patients
worldwide have reported persistent symptoms, such as dyspnea, reduced exercise capacity,
loss of taste/smell and fatigue months after the infection. Persistent symptoms are also
found in younger populations and in persons with an initially mild disease.

The intervention will take place at "Helse i Hardanger" (HiH)(Health center in Hardanger,
Norway). The participants will stay for a 3 -day rehabilitation intervention, if needed,
another 1 or 2-day stay will be offered about a month later. The concentrated treatment
will be given by an interdisciplinary team, including doctors, physiotherapists,
nutritionists, pharmacists, psychologists/psychiatrists, and nurses. The intervention is
an individualized group treatment based on behavioural change.

Unknown status
COVID19

Other: Concentrated rehabilitation for patients with persistent symptoms post COVID-19

3+ 1-2 days concentrated rehabilitation for patients with persistent symptoms post
COVID-19 with a mobile application follow-up and physical consultations at 3 months post
intervention.

Eligibility Criteria

Inclusion Criteria:

- persistent symptoms minimum 2 months post COVID-19 infection

- reduced exercise capacity level

- symptoms of dyspnea and/or fatigue

Exclusion Criteria:

- diseases where exercise is contraindicated (e.g. unstable angina pectoris)

- drug abuse, severe mental illness where treatment in groups are contraindicated.

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: 67 Years
Countries
Norway
Locations

Helse i Hardanger
Øystese, Kvam Herad, Norway

Contacts

Bente Frisk, PhD
+4797003111
bente.frisk@hvl.no

Kiri L Njøten, MSc
+4797519412
kilon@hvl.no

Gerd Kvale, PhD, Study Chair
University of Bergen

Helse-Bergen HF
NCT Number
Keywords
long COVID
post-acute COVID syndrome
persistent symptoms post COVID-19
MeSH Terms
COVID-19